Uniphar PLC
ISEQ:UPR
Net Margin
Uniphar PLC
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| IE |
U
|
Uniphar PLC
ISEQ:UPR
|
1.1B EUR |
2%
|
|
| US |
|
Mckesson Corp
NYSE:MCK
|
88.3B USD |
1%
|
|
| US |
|
Cencora Inc
NYSE:COR
|
59.1B USD |
1%
|
|
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
58.6B USD |
1%
|
|
| US |
|
Cardinal Health Inc
NYSE:CAH
|
36.4B USD |
1%
|
|
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
32.9B AUD |
0%
|
|
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
80.2B CNY |
8%
|
|
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
71.2B CNY |
2%
|
|
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW |
7%
|
|
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
8.3B USD |
3%
|
|
| AU |
E
|
EBOS Group Ltd
OTC:EBOSY
|
8.2B USD |
2%
|
Uniphar PLC
Glance View
Uniphar Plc engages in the provision of pre-wholesale and wholesale pharmaceutical distribution. The company is headquartered in Dublin, Dublin and currently employs 2,920 full-time employees. The company went IPO on 2019-07-17. The firm is a diversified healthcare services company. The company serves multinational pharmaceutical and medical technology manufacturers across three divisions: Commercial & Clinical, Product Access and Supply Chain & Retail. Through commercial & clinical division, the Company provides sales, marketing and distribution solutions to multinational pharmaceutical and medical device manufacturers on an outsourced basis. Product Access division offers two service offerings: On Demand Access and Exclusive Access. On Demand Access is a pharmacy led solutions for sourcing and supplying unlicensed medicines to meet the needs of both retail and hospital pharmacists. Exclusive Access is a manufacturer led solution for controlling the release of specialty medicines for specifically approved patient populations. Supply Chain & Retail provides both pre-wholesale distribution and wholesale distribution of pharmaceutical, healthcare and animal health products.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Uniphar PLC's most recent financial statements, the company has Net Margin of 2.3%.
You don't have any saved screeners yet